ArticleBMC nephrology2025
Classification of primary glomerulonephritis using machine learning models: a focus on IgA nephropathy prediction.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- IgA Nephropathy: Mechanisms, Risk Stratification, and Precision Therapy.Diagnostics (Basel, Switzerland) · 2026Review
- Development and validation of a single-nephron estimated glomerular filtration rate model to predict disease progression in IgA nephropathy.BMC nephrology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveIgA nephropathy (IgAN) is the most common form of glomerulonephritis worldwide, characterized by immune complex deposition in the glomerular mesangium, leading to mesangial hypercellularity, persistent microhematuria, proteinuria, and progressive renal impairment. Given its common occurrence, diagnosis normally involves renal biopsy, with its accompanying risks of bleeding and infection. In this study, multiple machine learning algorithms were used to develop a non-invasive and improved model for the diagnosis of IgAN. MATERIALS AND
methodsThis retrospective study included 292 patients with IgAN and 310 individuals with different nephropathies, utilizing 82 clinical variables, with kidney pathology results serving as ML labels. A random forest (RF) regression model addressed missing values. Subjects were divided into a development set (n = 542) and a test set (n = 60). The RF method was applied to select 17 key features for building diagnostic models, including the RF model, support vector machine (SVM), adaptive boosting (ADB), and traditional doctor judgment. Performance was evaluated using accuracy, sensitivity, specificity, and area under the curve (AUC) from receiver operating characteristic (ROC) analyses.
resultsThe random forest model performed best with an accuracy of 82.3% and an AUC of 0.89 on the test set, outstripping SVM with an AUC of 0.82 and ADB with an AUC of 0.88. High urinary protein, low serum albumin, and elevated IgG levels were the primary features correlated with IgAN.
conclusionIn this study, a non-invasive diagnostic model for IgAN was developed, with RF line and superior accuracy and clinical applicability. This further highlights the potential of ML-based approaches in reducing reliance on invasive procedures and providing opportunities for early IgAN diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.